Medical device briefs
Thursday, 05 February, 2009
Nanosonics has been granted approval by the Therapeutic Goods Administration to market its Trophon EPR device.
The device disinfects ultrasound probes and is aimed at hospitals, specialists and radiology clinics.
It has received earlier approval in the EU, Canada and New Zealand and is awaiting approval from the US FDA.
Polartechnics has signed agreements in Thailand, the Philippines, Indonesia and Sri Lanka for its TruScreen and CerviScreen diagnostics.
TruScreen is a point-of-care test for HPV while CerviScreen is a self-administered test.
Listed lab consumables company Fluorotechnics has changed its trading name to Gel Company. Its ASX name will remain the same.
Depression impacts energy at a cellular level, researchers find
Depression symptoms may be rooted in fundamental changes in the way brain and blood cells use...
Are discarded peanut shells the affordable and sustainable path to graphene?
Australian researchers have produced small quantities of high-quality graphene via a new process...
Aussie biotech to manufacture mRNA paediatric brain cancer vaccines
A Queensland-based biotechnology company will manufacture personalised mRNA paediatric brain...
